Top

States Try to Obscure Execution Details as Drugmakers Hinder Lethal Injection

Merck signs $922m deal with Opko Health unit for Epstein-Barr vaccine candidate

After Capping Insulin Copays, Colorado Sets Its Sights on EpiPens

Almond, Soy Drinks Can Be Called Milk, FDA Proposes

GSK and Vir Biotech amend COVID-19 research partnership

Tag: accelerated review

Cell and Gene Therapy, Industry

Sarepta asks FDA to approve first gene therapy for Duchenne muscular dystrophy

September 29, 2022

Via: Biopharma Dive

Sarepta Therapeutics has asked the Food and Drug Administration to approve its gene therapy for Duchenne muscular dystrophy under accelerated review, the company said Thursday. The biotechnology company’s application for SRP-9001, also known as delandistrogene moxeparvovec, is primarily based on […]